AACE Cardiometabolic Conference • September 30 - October 2, 2022
Each year experts from the field of endocrinology and cardiometabolic disease convene to collaborate, learn, and earn CME/CE through a combination of state-of-the-art-lectures, advanced learning experiences, engaging sessions, expert panel discussions, abstracts and more.
By the end of the meeting, participants will be able to:
- Utilize the latest clinical practice guidelines on cardiometabolic disease, including Type 2 diabetes and cardiovascular risk/heart failure, obesity, and chronic kidney disease.
- Discuss the key characteristics of evidence-based assessment and treatment options for patients with cardiometabolic disease
- Describe barriers in being able to manage the risk factors as well as the ability of patients to carry through recommendations for a healthier lifestyle.
- Explain cardiovascular risk management approaches that remain controversial without consensus as to best approach.
We're proud to bring you a full education program that was designed for the care team by the care team. Join your multidisciplinary peers for live state-of-the-art-lectures, advanced learning workshops, industry product theaters, abstracts, 11.5 CME/CE/MOC, and more.
This conference will focus on translational medicine and the clinical applications of evidence-based guidelines for the following topics:
- Obesity medicine, nutrition and wellness
- Type 2 diabetes and cardiovascular risk/health failure
- Chronic kidney disease, renal failure
- Diabetes technology
- SGLT-2s, GLP-1 RAS
- Patient challenges in ability to self manage chronic illness
Optimize and personalize your patient outcomes by immersing yourself in the most relevant clinical approaches and technology advances.
Now Accepting Abstracts • Deadline: Friday, July 29, 2022, at 11:59 pm ET
The abstract submission period is open now through Friday, July 29, 2022, at 11:59 pm ET. We invite you to submit an abstract for the unique opportunity to have your work reviewed by experts in the field of endocrinology and cardiometabolic disease. If accepted, your abstract will be published as a supplement to AACE’s medical journal, Endocrine Practice.